EURAMOS-1, an international randomised study for osteosarcoma: Results from pre-randomisation treatment
Antineoplastic Combined Chemotherapy Protocols
New models of collaboration are required to successfully conduct trials to improve outcomes of patients with rare cancers; EURAMOS-1 demonstrates achievability. Considerable regulatory, financial and operational challenges must be overcome to develop similar studies in the future. The trial is registered as NCT00134030 and ISRCTN 67613327.